Aug 3, 2026
Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard.
01:05 – Traditional diagnostic approaches
02:55 – PRECISION trial
05:03 – MRI challenges